Mads Kreilgaard - Concepedia

Author

Mads Kreilgaard

University of Copenhagen ORCID

Also Known As

Kreilgaard, M, Kreilgaard, Mads, M Kreilgaard, M. Kreilgaard, Mads Kreilgaard

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

University of Copenhagen Lundbeck (Denmark)Schools of Visual Arts, The Royal Danish Academy of Fine Arts Aarhus University Hospital Aalborg University Hospital

About

Mads Kreilgaard is an author at University of Copenhagen specializing in pharmacology, medicine, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	17	913
2	Health Sciences	7	7	134
3	Social Sciences	4	4	293
4	Anesthesia	3	3	56
5	Allergy	1	1	40

Mads Kreilgaard

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity <i>in vivo</i> Serhat Erbayraktar, Giovanni Grasso, Alessandra Sfacteria, Proceedings of the National Academy of Sciences	2003	437
NMR characterisation and transdermal drug delivery potential of microemulsion systems Mads Kreilgaard, Erik Jonas Pedersen, Jerzy W. Jaroszewski Journal of Controlled Release NanomedicineMedicineMicroemulsionDrug Delivery SystemsNmr Characterisation	2000	323
The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats Arne Mørk, Mads Kreilgaard, Connie Sánchez Neuropharmacology NeurophysiologyNeuroanatomyMedicinePhysiologyPsychopharmacology	2003	166
Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats Benny Bang‐Andersen, Ben Grayson, F.P. Bymaster, The International Journal of Neuropsychopharmacology	2010	103
Dermal Pharmacokinetics of Microemulsion Formulations Determined by In Vivo Microdialysis Mads Kreilgaard Pharmaceutical Research	2001	102
Influence of a Microemulsion Vehicle on Cutaneous Bioequivalence of a Lipophilic Model Drug Assessed by Microdialysis and Pharmacodynamics Mads Kreilgaard, Michiel J. B. Kemme, Jacobus Burggraaf, Pharmaceutical Research	2001	101
Using pharmacokinetic–pharmacodynamic modelling as a tool for prediction of therapeutic effective plasma levels of antipsychotics Christina Kurre Olsen, Lise T. Brennum, Mads Kreilgaard European Journal of Pharmacology Therapeutic Drug MonitoringPharmacokinetic ModelingPsychiatryPharmacokinetic–pharmacodynamic ModellingPsychotropic Medication	2008	64
R-citalopram inhibits functional and 5-HTP-evoked behavioural responses to the SSRI, escitalopram Connie Sánchez, Mads Kreilgaard Pharmacology Biochemistry and Behavior NeuropsychologyNeurophysiologyBehavioral Neuroscience5-Htp-evoked Behavioural ResponsesBehavioral Pharmacology	2004	54
Prediction of clinical response based on pharmacokinetic/pharmacodynamic models of 5‐hydroxytryptamine reuptake inhibitors in mice Mads Kreilgaard, David Glenn Smith, Lise T. Brennum, British Journal of Pharmacology	2008	51
Sertindole, in contrast to clozapine and olanzapine, does not disrupt water maze performance after acute or chronic treatment Michael Didriksen, Mads Kreilgaard, Jørn Arnt European Journal of Pharmacology Psychoactive DrugPsychiatryBehavioral NeuroscienceMedicineWater Maze Performance	2006	49

Page 1